Instituto de Oncologia Saint Gallen
Santa Cruz Do Sul, Rio Grande Do Sul, Brazil
Medical center in Santa Cruz do Sul, State of Rio Grande do Sul
R. Mal. Deodoro, 1139 - Centro, Santa Cruz do Sul - RS, 96810-110
About Instituto de Oncologia Saint Gallen
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
1
Pierre Fabre Medicament
1
Clinical Trials at Instituto de Oncologia Saint Gallen
During the past decade, Instituto de Oncologia Saint Gallen conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
2022-05-02
2035-05-02
Recruiting
815
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
2022-04-14
2027-10-01
Recruiting
900
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Oncologia Saint Gallen"
#1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Instituto de Oncologia Saint Gallen
According to Clinical.Site data, the most researched conditions in "Instituto de Oncologia Saint Gallen" are
"Abiraterone Acetate" (1 trials), "Androgens" (1 trials), "Antineoplastic Agents" (1 trials), "Antineoplastic Agents, Hormonal" (1 trials) and "Cyclin-Dependent Kinase 4" (1 trials). Many other conditions were trialed in "Instituto de Oncologia Saint Gallen" in a lesser frequency.
Clinical Trials Intervention Types at Instituto de Oncologia Saint Gallen
Most popular intervention types in "Instituto de Oncologia Saint Gallen" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib" (1 trials), "Abiraterone" (1 trials), "Encorafenib and Binimetinib" (1 trials), "Placebo for Abemaciclib" (1 trials) and "Placebo to match Encorafenib ; Placebo to match Binimetinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto de Oncologia Saint Gallen
The vast majority of trials in "Instituto de Oncologia Saint Gallen" are
1 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Instituto de Oncologia Saint Gallen
Currently, there are NaN active trials in "Instituto de Oncologia Saint Gallen".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Instituto de Oncologia Saint Gallen,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Oncologia Saint Gallen, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".